Connor, Clark & Lunn Investment Management (CC&L)’s Adaptive Biotechnologies ADPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-89,119
| Closed | -$681K | – | 1221 |
|
|
2022
Q4 | $681K | Sell |
89,119
-179,896
| -67% | -$1.37M | ﹤0.01% | 803 |
|
|
2022
Q3 | $1.92M | Buy |
269,015
+134,810
| +100% | +$960K | 0.01% | 504 |
|
|
2022
Q2 | $1.09M | Buy |
134,205
+112,987
| +533% | +$914K | 0.01% | 604 |
|
|
2022
Q1 | $295K | Buy |
21,218
+3,208
| +18% | +$44.6K | ﹤0.01% | 878 |
|
|
2021
Q4 | $505K | Sell |
18,010
-5,564
| -24% | -$156K | ﹤0.01% | 796 |
|
|
2021
Q3 | $801K | Buy |
+23,574
| New | +$801K | ﹤0.01% | 681 |
|